The present invention relates generally to a delivery catheter system that is adapted to deliver multiple devices, such as guide wires, with definite spacing between each of them. The present invention further relates to a translation mechanism of the delivery catheter system which allows a delivery catheter to move to a definite distance.
The left side of a human heart includes the left atrium (LA) and the left ventricle (LV). An aorta receives oxygenated blood from the left ventricle through an aortic valve, which serves to prevent regurgitation of blood back into the left ventricle. A mitral valve is positioned between the left atrium and the left ventricle and allows one-way flow of the oxygenated blood from the left atrium to the left ventricle.
Mitral valve, which will be described below in more detail, includes an anterior leaflet and a posterior leaflet that are coupled to chordae tendineae. Chordae tendineae serve as “tension members” that prevent the leaflets of the mitral valve from moving past their closing point and prolapsing back into the left atrium. When the left ventricle contracts during systole, chordae tendineae limit the upward motion (toward the left atrium) of the anterior and posterior leaflets past the point at which the anterior and posterior leaflets meet and seal to prevent backflow from the left ventricle to the left atrium (“mitral regurgitation” or “mitral insufficiency”). Chordae tendineae arise from a columnae carnae or, more specifically, a musculi papillares (papillary muscles) of the columnae carnae. In various figures herein, some anatomical features have been deleted solely for clarity.
The anterior leaflet and the posterior leaflet of the mitral valve are generally thin, flexible membranes. When the mitral valve is closed, the anterior leaflet and the posterior leaflet are generally aligned and contact one another along a “line of coaptation” several millimeters back from their free edges, to create a seal that prevents mitral regurgitation. Alternatively, when the mitral valve is opened, blood flows downwardly through an opening created between the anterior leaflet and the posterior leaflet into left ventricle.
Many problems relating to the mitral valve may occur and may cause many types of ailments. Such problems include, but are not limited to, mitral regurgitation. Mitral regurgitation, or leakage, is the backflow of blood from the left ventricle into the left atrium due to an imperfect closure of the mitral valve. That is, leakage often occurs when the anterior and posterior leaflets do not seal against each other, resulting in a gap between the anterior leaflet and the posterior leaflet when the leaflets are supposed to be fully coapted during systole.
In general, a relatively significant systolic gap may exist between the anterior leaflet and the posterior leaflet for a variety of different reasons. For example, a gap may exist due to congenital malformations, because of ischemic disease, or because the heart has been damaged by a previous heart attack. Such a gap may also be created when congestive heart failure, e.g., cardiomyopathy, or some other type of distress which causes a heart to be enlarged. Enlargement of the heart can result in dilation (stretching) of the mitral annulus. This enlargement is usually limited to the posterior valve annulus and is associated with the posterior leaflet, because the anterior annulus is a relatively rigid fibrous structure. When the posterior annulus enlarges, it causes the posterior leaflet to move away from the anterior leaflet, causing a gap during systole because the two leaflets no longer form proper coaptation. This results in leakage of blood through the valve or regurgitation.
Blood leakage through the mitral valve generally causes a heart to operate less efficiently, as the heart pumps blood both out to the body via the aorta, and also back (in the form of mitral regurgitation) into the left atrium. Leakage through the mitral valve, or general mitral insufficiency, is thus often considered to be a precursor to congestive heart failure (CHF) or a cause of progressive worsening of heart failure. There are generally different levels of symptoms associated with heart failure. These levels are classified by the New York Heart Association (NYHA) functional classification system. The levels range from a Class 1 level which is associated with an asymptomatic patient who has substantially no physical limitations to a Class 4 level which is associated with a patient who is unable to carry out any physical activity without discomfort and has symptoms of cardiac insufficiency even at rest. In general, correcting or reducing the degree of mitral valve leakage may be successful in allowing the NYHA classification grade of a patient to be reduced. For instance, a patient with a Class 4 classification may have his classification reduced to Class 3 or Class 2 and, hence, be relatively comfortable at rest or even during mild physical exertion. By eliminating the flow of blood backwards into the left atrium, therapies that reduce mitral insufficiency reduce the workload of the heart and may prevent or slow the degradation of heart function and congestive heart failure symptoms that is common when a significant degree of mitral insufficiency remains uncorrected.
Treatments used to correct for mitral valve leakage or, more generally, CHF, are typically highly invasive, open-heart surgical procedures. In extreme cases, this may include implantation of a ventricular assist device such as an artificial heart in a patient with a failing heart. The implantation of a ventricular assist device is often expensive, and a patient with a ventricular assist device must be placed on extended anti-coagulant therapy. Anti-coagulant therapy reduces the risk of blood clot formation for example, within the ventricular assist device. Reducing the risks of blood clots associated with the ventricular assist device is desirable, but anti-coagulant therapies may increase the risk of uncontrollable bleeding in a patient, e.g., as a result of a fall.
Rather than implanting a ventricular assist device, bi-ventricular pacing devices similar to pacemakers may be implanted in some cases, e.g., cases in which a heart beats inefficiently in a particular asynchronous manner. While the implantation of a bi-ventricular pacing device may be effective, not all heart patients are suitable for receiving a bi-ventricular pacing device. Further, the implantation of a bi-ventricular pacing device is expensive, and is generally not effective in significantly reducing or eliminating the degree of mitral regurgitation.
Open-heart surgical procedures that are intended to correct for mitral valve leakage, specifically, can involve the implantation of a replacement valve. Valves from animals, e.g., pigs, may be used to replace a mitral valve in a human. While a pig valve as a replacement for the mitral valve may be relatively successful, such replacement valves generally wear out, thereby requiring additional open surgery at a later date. Mechanical valves, which are less likely to wear out, may also be used to replace a leaking mitral valve. However, when a mechanical valve is implanted, there is an increased risk of thromboembolism, and a patient is generally required to undergo extended anti-coagulant therapies.
A less invasive surgical procedure involves heart bypass surgery associated with a port access procedure. For a port access procedure, the heart may be accessed by cutting between ribs or sometimes removing parts of one or more ribs, as opposed to dividing the sternum to open the entire chest of a patient.
One open-heart surgical procedure that is particularly successful in correcting a mitral valve leakage and, in addition, mitral regurgitation, is an annuloplasty procedure. During an annuloplasty procedure, a medical device such as an annuloplasty ring may be implanted surgically on the left atrial side of mitral annulus (i.e., generally the attachment location of the base of the mitral valve to the heart). The device reduces a dilated mitral valve annulus to a relatively normal size and, specifically, moves the posterior leaflet closer to the anterior leaflet to aid anterior-posterior leaflet coaptation and thus improve the quality of mitral valve closure during systole. Annuloplasty rings are often shaped substantially like the letter “D” to correspond to the natural shape of the mitral annulus as viewed from above. Typically, the rings are formed from a rod or tube of biocompatible material, e.g., plastic, that has a DACRON mesh covering.
In order for an annuloplasty ring to be implanted, a surgeon surgically attaches the annuloplasty ring to the mitral valve on the atrial side of the mitral valve. Conventional methods for installing a ring require open-heart surgery which involves opening a patient's sternum and placing the patient on a heart bypass machine. The annuloplasty ring is sewn on a top portion of the mitral valve. In sewing the annuloplasty ring onto the mitral valve, a surgeon generally sews the straight side of the “D” to the fibrous tissue located at the junction between the posterior wall of the aorta and the base of the anterior mitral valve leaflet. As the curved part of the ring is sewn to the posterior aspect of the annulus, the surgeon alternately acquires a relatively larger amount of tissue from the mitral annulus, e.g., a one-eighth inch bite of tissue, using a needle and thread, compared to a relatively smaller bite taken of the fabric covering of the annuloplasty ring. Once the thread has loosely coupled the annuloplasty ring to the mitral valve annulus tissue, the annuloplasty ring is slid into contact with the mitral annulus. The tissue of the posterior mitral annulus that was previously stretched out, e.g., due to an enlarged heart, is effectively reduced in circumference and pulled forwards towards the anterior mitral leaflet by the tension applied by annuloplasty ring with the suture or thread. As a result, a gap between the anterior leaflet and the posterior leaflet during ventricular contraction or systole may be reduced and even substantially closed off in many cases thereby significantly reducing or even eliminating mitral insufficiency. After the mitral valve is shaped by the ring, the anterior and posterior leaflets will reform typically by pulling the posterior leaflet forward to properly meet the anterior leaflet and create a new contact line that will enable the mitral valve to appear and to function properly.
Although a patient that receives an annuloplasty ring may be subjected to anti-coagulant therapies, therapies are not extensive, as a patient is only subjected to therapies for a matter of weeks, e.g., until tissue grows over the annuloplasty ring.
Another type of procedure that is generally effective in reducing mitral valve leakage associated with prolapse of the valve leaflets involves placing a single edge-to-edge suture in the mitral valve that opposes the mid-portions of anterior and posterior leaflets. For example, in an Alfieri stitch or a bow-tie repair procedure, an edge-to-edge stitch is made at approximately the center of the gap between an anterior leaflet and a posterior leaflet of a mitral valve. Once the stitch is in place between the anterior and posterior leaflets, it is pulled in to form a suture which holds the anterior leaflet against the posterior leaflet.
Another surgical procedure that reduces mitral valve leakage involves placing sutures along a mitral valve annulus around the posterior leaflet. These sutures may be formed as a double track, e.g., in two “rows” from a single strand of suture material. The sutures are tied off at approximately a central point of posterior leaflet. Pledgets are often positioned under selected sutures to prevent the sutures from tearing through annulus. When the sutures are tightened and tied off, the circumference of the annulus may effectively be reduced to a desired size such that the size of a systolic gap between posterior leaflet and an anterior leaflet may be reduced.
While invasive surgical procedures have proven to be effective in the treatment of mitral valve leakage, invasive surgical procedures often have significant drawbacks. Any time a patient undergoes open-heart surgery, there is a risk of infection. Opening the sternum and using a cardiopulmonary bypass machine has also been shown to result in a significant incidence of both short and long term neurological deficits. Further, given the complexity of open-heart surgery, and the significant associated recovery time, people that are not greatly inconvenienced by CHF symptoms, e.g., people at a Class 1 classification, may choose not to have corrective surgery. In addition, people that need open heart surgery the most, e.g., people at a Class 4 classification, may either be too frail or too weak to undergo the surgery. Hence, many people that may benefit from a surgically repaired mitral valve may not undergo surgery.
In another method, a cinching device is placed within the coronary sinus (CS) using a catheter system, with distal, mid, and proximal anchors within the lumen of the CS to allow plication of the annulus via the CS. In practice, these anchors are cinched together and the distance between them is shortened by pulling a flexible tensile member such as a cable or suture with the intent being to shorten the valve annulus and pull the posterior leaflet closer to the anterior leaflet in a manner similar to an annuloplasty procedure. Unfortunately, since the tissue that forms the CS is relatively delicate, the anchors are prone to tear the tissue during the cinching procedure. In addition, the effect on the mitral annulus may be reduced when the CS of a particular patient is not directly aligned with the mitral annulus. Other minimally invasive techniques have been proposed but have various drawbacks related to such factors as effectiveness and/or accuracy of catheter-based implementation.
Catheter-based surgical procedures have been used to repair a defective mitral valve. Specifically, anchors are secured at a plurality of locations distributed around the annulus near the posterior leaflet of a mitral valve. Each anchor has a suture coupled thereto. The sutures are collectively gathered and pulled tight. As the sutures are pulled, the tissue between each pair of adjacent anchors is plicated, thereby shortening the length of the annulus and drawing the posterior leaflet toward the anterior leaflet. Similar techniques can also be used to repair a defective tricuspid valve.
During a surgical procedure, anchors are usually introduced and secured sequentially. A typical repair by using the catheter based surgical procedure involves a sequence that includes introducing a catheter to a proximity of the annulus, making an incision at the annulus, introducing a guide wire through the incision site, withdrawing the catheter, introducing an anchor by tracking a second catheter through the guide wire, securing the anchor in the annulus, and withdrawing the second catheter. This sequence is repeated to secure a second anchor.
Catheters capable of delivering multiple guide wires or anchors have been disclosed. Without claiming to have exhaustively examined prior art references and without attempting to characterizing any prior art reference, U.S. Patent Application Publication No. 2008-0228265 discloses a triple lumen catheter. However, distances between two of the three lumens are usually fixed. In addition, during a deployment, the two outer catheters are generally advanced lengthwise as well as laterally. In certain instances, one or both of the two outer catheters are caught by chordae tendineae during the deployment.
There is generally a need for an improved catheter to simplify the catheter-based mitral valve correction.
One aspect of the present teachings generally relates to translation catheter systems. The catheter system comprises a first wire configured to be positioned at a first location, a second catheter configured to be positioned at a second location, and a translation element configured to move the second catheter from the first location to the second location in a substantially linear fashion. A first wire is positioned with the first catheter. The translation element operably connects the first and second catheters.
In one aspect of the present teachings, the translation element of the catheter system is a tether. The tether comprises a free end and the free end wraps around one of the first and second catheter. In one aspect of the present teachings, the tether comprises a fixed end and the fixed end. The fixed end is connected with one of the first and second catheter, and the free end extends into a lumen of the other catheter.
In another aspect of the present teachings, the translation element of the catheter system is a bar formed of at least two segments. In another aspect of the present teachings, the translation element of the catheter system comprises an anchor configured to track over the first wire, and a tether. The tether has a proximal end and a distal end, wherein the distal end of the tether connects the anchor.
In one aspect of the present teachings, the distal portions of the first and the second catheters are connected. In one aspect of the present teachings, the second catheter is flexible. In one aspect of the present teachings, the second catheter comprises at least one side opening. In one aspect of the present teachings, the distance between the first location and the second location is adjustable.
Another aspect of the present teachings generally relates to translation catheter systems where translation catheter systems have a first catheter configured to be positioned at a first treatment location; a second catheter configured to be positioned at a second treatment location; and a translation mechanism operably connecting the first and second catheters. In one aspect of the present teachings, the translation mechanism is configured to allow the second catheter to move laterally away from the first catheter to any distance.
Another aspect of the present teachings generally relates to translation catheter systems where translation catheter systems have a first guide wire positioned at a first treatment location; a tracking anchor configured to track over the first guide wire; a second catheter configured to be positioned at a second treatment location; and a tether having a proximal end and a distal end. The distal end of the tether connects to the tracking anchor and the proximal end of the tether extends through a central lumen of the second catheter.
Another aspect of the present teachings generally relates to translation catheter systems where translation catheter systems have a first catheter configured to be positioned at a first treatment location; a second catheter configured to be positioned at a second treatment location; and a tether having a proximal end and a distal end. The distal end of the tether connects to the first catheter and the proximal end of the tether extends through a central lumen of the second catheter.
Another aspect of the present teachings generally relates to translation catheter systems where translation catheter systems have a first catheter comprising a distal end configured to be positioned at a first treatment location; a second catheter comprising a distal end configured to be positioned at a second treatment location; and a connecting bar connecting the distal ends of the first and second catheters. The connecting bar has at least two segments with at least one pivot between the segments.
Another aspect of the present teachings generally relates to translation catheter systems where translation catheter systems have a first catheter comprising a distal end configured to be positioned at a first treatment location; and a second catheter comprising a distal end configured to be positioned at a second treatment location. The second catheter is configured to be bendable in one direction and the distal ends of the first and second catheters are joined to each other.
Certain specific details are set forth in the following description and Figures to provide an understanding of various embodiments of the present teachings. Those of ordinary skill in the relevant art will understand that they can practice other embodiments of the present teachings without one or more of the details described herein. Thus, it is not the intention of the Applicants to restrict or in any way limit the scope of the appended claims to such details. While various processes are described with reference to steps and sequences in the following disclosure, the steps and sequences of steps should not be taken as required to practice all embodiments of the present teachings.
As used herein, the terms “subject” and “patient” refer to an animal, such as a mammal, such as livestock, pets, and preferably a human. Specific examples of “subjects” and “patients” include, but are not limited to, individuals requiring medical assistance and, in particular, requiring treatment for symptoms of a heart failure.
As used herein, the term “lumen” means a canal, duct, generally tubular space or cavity in the body of a subject, including veins, arteries, blood vessels, capillaries, intestines, and the like. The term “lumen” can also refer to a tubular space in a catheter, a sheath, or the like in a device.
As used herein, the term “proximal” means close to the operator (less into the body) and “distal” shall mean away from the operator (further into the body). In positioning a medical device from a downstream access point, distal is more upstream and proximal is more downstream.
While the description above refers to and the term “tether” means a tensioning member which can take forms of a suture, a wire, a strand, a cord, a fiber, a yarn, a filament, a cable, a thread, or the like. Thus, all these terms are essentially interchangeable and further include embodiments in which the wire, string, suture or filament is a hollow tube or conduit to allow another wire, as needed, to pass through its longitudinal axis. Each tether, wire, string, suture and filament can comprise one or more tethers, wires, strings, sutures and filaments. Material used to make tether could be flexible, semi-rigid, or rigid material having a suitably high tensile strength for the intended use.
As used herein, the term “catheter” or “sheath” encompasses any hollow instrument capable of penetrating body tissue or interstitial cavities and providing a conduit for selectively injecting a solution or gas. The term “catheter” or “sheath” is also intended to encompass any elongate body capable of serving as a conduit for one or more of the ablation, expandable or sensing elements. Specifically, in the context of coaxial instruments, the term “catheter” or “sheath” can encompass either the outer catheter body or sheath or other instruments that can be introduced through such a sheath. The use of the term “catheter” should not be construed as meaning only a single instrument but rather is used to encompass both singular and plural instruments, including coaxial, nested, and other tandem arrangements. Moreover, the terms “sheath” or “catheter” are sometime used interchangeably to describe catheters having at least one lumen through which instruments or treatment modalities can pass.
Unless otherwise specified, all numbers expressing quantities, measurements, and other properties or parameters used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless otherwise indicated, it should be understood that the numerical parameters set forth in the following specification and attached claims are approximations. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, numerical parameters should be read in light of the number of reported significant digits and the application of ordinary rounding techniques.
An aspect of the present teachings provides a delivery catheter system for delivering multiple guide wires across mitral annulus at a controlled spacing between each of them. In various embodiments, the delivery catheter system has one catheter and a translation mechanism allowing the catheter to move to a second location, i.e. translate, from its first location by a distance, pre-defined or determined by a clinician during procedure. In some embodiments, the delivery catheter system includes two catheters and a translation mechanism allowing the at least one catheter to move away from the other catheter by a distance, pre-defined or determined by a clinician during procedure. In some embodiment, the distance between the first and second locations, or the distance between the first and second catheter after translation, are within the range of 1-40 mm. In some embodiment, the translation mechanism of the delivery catheter system includes a tether, a shuttle, a tracking element, a wire, a coil, a connecting bar with a pivot, or a combination thereof. In some embodiments, the translation is lateral. In other embodiments, the translation is distal-lateral. In some embodiments, the translation is continuous. In other embodiments, the translation is step-by-step. In some embodiments, the distance of the translation is adjustable. In other embodiments, the distance of the translation is pre-defined.
Another aspect of the present teachings provides method of delivering a translation catheter system to a first location at or approximate to the mitral annulus, translating the translation catheter system to a second location at or approximate to the mitral annulus. In various embodiments, the distance between the two locations is controlled by a clinician. In various embodiments, the method includes advancing a first delivery catheter to a first location at or approximate to the mitral annulus, placing a wire across the mitral annulus at this first location, translating the first catheter to a second location at or approximate to the mitral annulus, placing a second wire across the mitral annulus at the second location. In various embodiments, the method includes advancing a first delivery catheter to a first location at or approximate to the mitral annulus, placing a wire across the mitral annulus at this first location, translating the second catheter to a second location at or approximate to the mitral annulus, placing a second wire across the mitral annulus at the second location.
The following description refers to
In some embodiments, the distal end (12) of the first catheter (10) includes a radio-opaque and/or echogenic marker so that the device can be visualized by using a radiographic imaging equipment, for example, x-ray, magnetic resonance, ultrasound, or fluoroscopic techniques.
In various embodiments, the first wire (20) has a delivery profile where the distal end (22) of the first wire (20) is disposed inside the lumen (16) of the first catheter (10). In some embodiments, when the distal end (22) of the first wire (20) is disposed within the lumen (16) of the catheter (12), the entire first wire (20) is substantially straight and parallel with the long axis of the first catheter (10). In some embodiments, the first wire (20) has a deployed profiled where the distal end (22) of the first wire (20) extends distally outside the lumen (16) of the first catheter (10), as illustrated in
In various embodiments, the first wire (20) is pre-loaded within the lumen (16) of the first catheter (10). In various other embodiments, the first wire (20) is advanced after the first catheter (10) is placed at a treatment location.
In various embodiments, the first wire delivery catheter (10) is generally perpendicular to the annulus (2) before the first wire (20) pierces and crosses the annulus (2). Once the first catheter (10) is properly positioned, a clinician extends the first wire (20) distally so that the distal tip (26) of the first wire (20) pierces and crosses the annulus (2) at the first location (4). In some embodiments, a radio frequency energy is applied to assist the distal tip (26) of the first tissue piercing wire (20) to pierce and cross the annulus (2) and reach the left atrium. To determine when to stop the distal extension force to the wire (20), in some embodiments, a change of the counter force on the first wire (20) indicates that the annulus (2) is pierced or the distal tip (26) of the first wire (20) reaches a side wall of the left atrium. Alternatively, visualization techniques, including three-dimensional echocardiogram, fluoroscopy, or magnetic resonance imaging techniques, can be used.
As illustrated in
Further referring to
In an exemplary embodiment as shown in
To deliver the second wire (40) across the annulus (2), a clinician slides the tracking element (52) over the proximal end of the first wire (20) and affixes the tether (50) to the tracking element. The tether (50) and the tracking element (52) are loaded inside the second wire delivery catheter (30). By tightening the tether (50), the distal end (34) of the second catheter (30) maintains a close proximity to the first wire (20). The tracking element (52) and the second catheter (30), optionally disposed inside a delivery sheath (8), tracks along the first wire (20) and extends distally. Once the distal end (34) of the second catheter (30) arrives at or near to the first location (4) of the annulus (2), the tether (50) is loosened and the second catheter (30) is steered away from the first location (4) of the annulus (2) to the second location (6) on the annulus (2). In some embodiments, the translation of the second catheter (30) from the first location (4) is lateral. In other embodiments, the translation of the second catheter (30) from the first location (4) is continuous. In yet another embodiment, the translation distance of the second catheter (30) from the first location is adjustable.
In various embodiments, the second wire delivery catheter (30) is generally perpendicular to the annulus (2) before the second wire (40) pierces the annulus (2). The second wire (40) is advanced distally to pierce and cross the annulus (2) at the second location (6) in a manner similar to those described herein in connection with
In some embodiments, the distal end (34) of the second catheter (30) remains close to the annulus (2) the entire time when the second catheter is steered from the first location to the second location. Without intending to limit the scope of the present teachings, such a lateral movement avoids the distal end of the second catheter from being caught, snag, or hung up by tissues in the left ventricle, and allows the second catheter (30) pushing away any anatomy in the path of the translation. In some embodiments, the distal end (34) of the second catheter (30) remains close to the annulus (2) the entire time when it is steered from the first location to the second location.
In one embodiment, a clinician controls the distance between the first and second locations (4, 6) by controlling the length of the tether (50) between the distal end of the second catheter and the first wire. According to some embodiments, such the mechanism as shown in
In some embodiments, during the delivery of the second catheter (30), a delivery sheath (8) is used, as seen in
In one embodiment, the tether (50) extends from the tracking element (52), enters the side opening (38) of the second catheter (30), extends proximally along the center lumen (32) of the second catheter (30), and exits the body, as illustrated in
In one embodiment, the first wire delivery catheter (10) and the second wire delivery catheter (30) are different, where the first catheter (10) does not have any attachment mechanism with a tether (50) but the second catheter (30) has. In another embodiment, the first wire delivery catheter (10) and the second wire delivery catheter (30) are the same. In the later embodiment, an attachable/detachable tracking system (60) is used for converting the first catheter to a tethered second catheter. As illustrated in
In one embodiment, as shown in
In another embodiment, one end of the tether (66) is fixed to one tracking anchor (62), riding over the first wire (20), and the other end of the tether (66) enters the other tracking anchor (64) in a manner similar to those described in connection with
In various embodiments, at least one of the second catheter and the tether includes a radio-opaque marker or is made in part or its entirety of a radio-opaque material. By using a visualization technique, including various ultrasound, x-ray, fluoroscopic, or magnetic resonance imaging techniques, a clinician can use the marker to visualize where the first catheter, the second catheter, and/or the tether are located in the anatomy. A clinician can also use the marker to determine the translation distance of the second catheter or the distance between the two treatment locations. In one exemplary embodiment, the tether could have multiple markers which to indicate the translation distance, and allow a clinician to control the distance between the two treatment locations.
Referring to
In various embodiments, a second catheter (30) continuously and adjustably translates away from a first catheter (10) via a tethering mechanism. Now referring to
Similarly, the length of the loosened tether (50) determines the distance between the second catheter (30) and the first catheter (10). According to some embodiments, such the mechanism as shown in
In some embodiments, in order to maintain a generally perpendicular position between the distal end (34) of the second catheter (30) and the annulus (2), the second catheter (30) includes a curved portion (68) near its distal end, as shown in
According to some embodiments, a piece of rigid material could be incorporated to the distal portion of the tether (50) in between of the two catheters (10,30) to ensure a minimal translation distance. In one embodiment, either one of the catheters (10,30) is configured to be articulated. In another embodiment, both of the catheters (10,30) are configured to be articulated.
In many embodiments, the design, material, and/or construct of the first catheter and the second catheter are interchangeable. Specifically, for example, in many of the embodiments described herein, the first catheter maintains its substantially straight configuration while the second catheter is steered away towards the second treatment location. One of ordinary skill in the art would understand that it is equally feasible to have a translatable deliver catheter system where the second catheter maintain its straight profile while the first catheter is steered to push the second catheter to the second treatment site. Thus, parts or portions in connection with the first and second catheters are interchangeable without departing from the letter or the spirit of the present teachings. In various embodiments, at least one of the first catheter, the second catheter, and the tether includes a radio-opaque marker or is made in part or its entirety of a radio-opaque material. By using a visualization technique, including various ultrasound, x-ray, fluoroscopic, or magnetic resonance imaging techniques, a clinician can use the marker to visualize where the first catheter, the second catheter, and/or the tether are located in the anatomy. A clinician can also use the marker to determine the translation distance of the second catheter or the distance between the two treatment locations. In one exemplary embodiment, the tether could have multiple markers which to indicate the translation distance, and allow a clinician to control the distance between the two treatment locations.
As shown in
According to another embodiment, instead of extending a second wire (40) directly inside the second catheter (80), a third wire delivery catheter is used to ride inside the lumen of the second catheter (80).
In some embodiments, the hinge (90) is in the shape of a coil, a roll, a reel, a spool or alike. In some embodiments, the hinge (90) is closed, open, or relatively neutral at its normal state. In other embodiments, by torqueing the distal end of one catheter, the hinge changes from one profile to another. In some embodiments, the hinge (90) has a contoured cross section such that it lies flat against the longitudinal surface of the catheters when wrapped around the distal end portions of the first and second catheters (10, 30). In other embodiments, when the cross section of the hinge straightens, the hinge becomes somewhat rigid, similar to the behavior of a stainless steel tape measure. In some embodiments, the hinge (90) includes multiple radio-opaque markers so that a clinician can visualize the translation distance and control the distance between the two treatment locations.
Similar to those described herein,
In various embodiments, at least one of the first catheter, the second catheter, and the flexible hinge includes a radio-opaque marker or is made in part or its entirety of a radio-opaque material. By using a visualization technique, including various ultrasound, x-ray, fluoroscopic, or magnetic resonance imaging techniques, a clinician can use the marker to visualize where the first catheter, the second catheter, and/or the hinge are located in the anatomy. A clinician can also use the marker to determine the translation distance of the second catheter or the distance between the two treatment locations. In one exemplary embodiment, the hinge could have multiple markers which to indicate the translation distance, and allow a clinician to control the distance between the two treatment locations.
In some embodiments, the second catheter (120) is operably joined to the outer translation catheter (104) of the first catheter (100) at their distal end by at least one connecting bar (140). Optionally, a third catheter (130) is operably joined to the outer translation catheter (104) of the first catheter (100) at their distal end by at least one connecting bar (140). In some embodiments, while the inner wire delivery catheter (102) is maintained steady, advancing the outer translation catheter (104) distally causes the connecting bars (140) to push the second and third catheters (120, 130) laterally outward and increase the distance among the distal ends of the catheters, as shown in
Without intending to limit the scope of the present teachings, such a lateral movement of the distal portion of the second and third catheters (120, 130) avoids the second and third catheters (120, 130) from being caught, snag, or hung up by tissues in the left ventricle. In addition, according to some embodiment, as the distal portion of the second and third catheters (120, 130) translates to the second and third treatment location, the second and third catheters (120, 130) pushes away any anatomy in the path of the translation. In some embodiments, the translation of the second and third catheters (120, 130) from the first location (4) is lateral. In other embodiments, the translation of the second and third catheters (120, 130) from the first location (4) is continuous. In yet another embodiment, the translation distance of the second and third catheters (120, 130) from the first location is adjustable.
In some embodiments, the second catheter (120) is at one side of the first catheter (100) and the third catheter (130) is at the other side of the first catheter (100). In some embodiments, the first catheter (100) delivers a first wire (142) across the mitral annulus (2) at a first location (4), the second catheter (120) delivers a second wire (144) across the mitral annulus (2) at a second location (6), and the third catheter (130) delivers a third wire (146) across the mitral annulus (2) at a third location (5). In some embodiments, all three wires (142, 144, 146) are delivered across the annulus (2) simultaneously. In other embodiments, the second and third wires (144, 146) are delivered across the annulus (2) simultaneously. In yet other embodiments, all three wires (142, 144, 146) are delivered across the annulus (2) sequentially. In certain embodiments, the first wire (142) advances across the annulus (2) first, the second wire (144) advances across the annulus (2) second, and the third wire (146) advances across the annulus last.
In some embodiments, the first wire (142) is delivered across the annulus (2) by a single lumen wire delivery catheter (not shown) in a manner similar to those described in connection with
In some embodiments, the distal ends of the second and third catheters (120, 130) are always leveled with the distal end of the first catheter (100) during translation. That is, the distal ends of all three catheters are within a same proximity to the mitral annulus (2). Thus, when the second and third catheters (120, 130) translate laterally outward, they push away any tissue in their paths.
According to one embodiment of the present teachings, by visualizing the angle “θ” between the connecting bars (140) and the inner wire delivery catheter (102), as illustrated in
In some embodiments, the at least one connecting bar (110) is made of a wire and the at least one pivot (114) is made of a single or double coil in the bar. In other embodiments, the at least one pivot (114) is achieved by breaking or disconnecting at least half of the cross section of the connecting bar (110), as shown in
In some embodiments, as shown in
In various embodiments, the segmented connecting bar (110) reduces the space required for the distal-lateral movement of the second catheter (30) during translation, comparing to a non-segmented connecting bar. In other embodiments, the at least one segmented connecting bar (110) each includes two or more segments. In yet other embodiments, the at least one segmented connecting bar (110) each includes three or more segments (112) and two or more pivots (114) between each pair of segments.
In some embodiment, after the first wire (20) is put in place and the first catheter (10) is held steady, a clinician steers the distal end of the second catheter (30) laterally away from the distal end of the first catheter (10) causing the connecting bar (150) to unbend. Such a lateral translation of the second catheter (30) pushes away or rides over any tissues in its path and reduces the possibility of the second catheter being caught by the tissues.
According to one embodiment of the present teachings, by visualizing the angle formed between the two segments, a clinician can visualize and control the actual translation distance. Similar to various embodiments disclosed in the present teachings, the embodiments described in connection with
According to some embodiments of the present teaching, the steerable sheath body (202) is configured to be steerable. As illustrated in
According to one embodiment, as the proximal end of a first longitudinal wire (222a) is retracted, the first wire coil (224a) is shortened, and distal portion (210) of the steerable sheath body (202) is steered toward the direction where the first steering wire (216) resides. In another embodiment, as the proximal end of a second longitudinal wire (222b) is retracted, the second wire coil (224b) is shortened, and distal portion (210) of the steerable sheath body (202) is steered toward the direction where the second steering wire (220) resides. Thus, by manipulating either the first or the second longitudinal wires (216, 220), the distal end (212) of the steerable sheath body (202) can be steered to the direction as desired.
According to some embodiments, the steerable bi-lumen translation catheter system (200) further includes two wire delivery catheters (230, 240) as illustrated in
According to some embodiments, the second wire delivery catheter (240) is configured to translate laterally to a first distance from sheath body (202). As described above, the second wire delivery catheter (240) is slidably disposed within the second longitudinal wire delivery catheter lumen (206). The distal portion (244) of the second wire delivery catheter (240) resides within the slot (214) at the distal portion (210) of the steerable sheath body (202) as shown in
According to some embodiments of the present teaching, a clinician pushes the proximal end of the translation rod (250), the distal end (252) of the translation rod (250) then pushes on the distal end (242) of the second wire delivery catheter (240). The distal portion (244) of the second wire delivery catheter (240) is then pushed outside of the slot (214) of the steerable sheath body (202), and continue moving laterally to a first distance as illustrated in
According to some embodiment, as illustrated in
In some embodiments, the distal end (252) of the translation rod (250) connects to the distal end (242) of the second wire delivery catheter (240). In another embodiment, the distal end (252) of the translation rod (250) connects to a location along the distal portion (244) of the second wire delivery catheter (240). In some embodiment, the translation rod has a cross section size of 2-25 mm, and made of nitinol. Alternatively, the translation rod could be made of any suitable material known to those skilled in the art.
According to some embodiments, the steerable bi-lumen translation catheter system (200) with the second wire delivery catheter (240) collapsed inside the slot (214) of the steerable sheath body (202) is delivered together to the mitral annulus (2). When needed, the distal end of the steerable bi-lumen translation catheter system (200) is steered to the desired location by a clinician pulling on one or both of the steering wires (216, 220). While the first wire delivery catheter (230) is generally maintained perpendicular to the annulus (2) at the first treatment location (4), a first wire is advanced across the annulus (2) in a manner similar to those described in connection with
In various embodiments, a second wire delivery catheter (240) continuously and adjustably translates away from a wire delivery catheter (230) and the distal portion (210) of the steerable bi-lumen translation catheter system (200) by pushing the translation rod (250) by a clinician. While holding the first wire in place, a clinician pushes the translation rod (250) to allow the distal end (242) of the second wire delivery catheter (240) to be steered away laterally outside of the slot (214) of the steerable bi-lumen translation catheter system (200). Similar to what has been described above, without intending to limit the scope of the present teachings, such a lateral movement avoids the distal end (242) of the second wire delivery catheter (240) from being caught, snag, or hung up by tissues in the left ventricle, and allows the second wire delivery catheter (240) pushing away any anatomy in the path of the translation.
Similarly, the length of the translation rod (250) determines the distance between the second wire delivery catheter (240) and the first wire delivery catheter (230). According to some embodiments, while the second wire delivery catheter (240) is maintained generally perpendicular to the annulus (2) at its second treatment location, a second tissue piercing wire is advanced across the annulus (2) in a manner similar to those described in connection with
The translation catheter system (200) disclosed above are useful for delivering multiple wires across mitral annulus. One skilled in the art will further recognize that the translation catheter system (200) according to the present teachings could be used to deliver multiple wires across tricuspid annulus, or other heart tissue. In addition, the translation catheter system (200) according to the present teachings could be used to deliver tissue anchors, or other medical implants across a heart tissue.
Various embodiments have been illustrated and described herein by way of examples, and one of ordinary skill in the art will appreciate that variations can be made without departing from the spirit and scope of the present teachings. The present teachings are capable of other embodiments or of being practiced or carried out in various other ways, for example in combinations. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this present teachings belong. Methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present teachings. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
The present application is a divisional of U.S. patent application Ser. No. 14/210,967, filed Mar. 14, 2014 (now U.S. Pat. No. 9,724,195), which claims the benefit of U.S. provisional patent application Ser. No. 61/786,373, filed Mar. 15, 2013, which are hereby incorporated by reference as if expressly set forth in their respective entireties herein.
Number | Name | Date | Kind |
---|---|---|---|
3604488 | Wishart et al. | Sep 1971 | A |
3656185 | Carpentier | Apr 1972 | A |
3840018 | Heifetz | Oct 1974 | A |
3881366 | Bradley et al. | May 1975 | A |
3898701 | La Russa | Aug 1975 | A |
4042979 | Angell | Aug 1977 | A |
4118805 | Reimels | Oct 1978 | A |
4214349 | Munch | Jul 1980 | A |
4245624 | Komiya | Jan 1981 | A |
4261342 | Aranguren Duo | Apr 1981 | A |
4290151 | Massana | Sep 1981 | A |
4434828 | Trincia | Mar 1984 | A |
4473928 | Johnson | Oct 1984 | A |
4602911 | Ahmadi et al. | Jul 1986 | A |
4625727 | Leiboff | Dec 1986 | A |
4712549 | Peters et al. | Dec 1987 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4778468 | Hunt et al. | Oct 1988 | A |
4881524 | Boebel | Nov 1989 | A |
4917698 | Carpentier et al. | Apr 1990 | A |
4961738 | Mackin | Oct 1990 | A |
5042707 | Taheri | Aug 1991 | A |
5061277 | Carpentier et al. | Oct 1991 | A |
5064431 | Gilbertson et al. | Nov 1991 | A |
5104407 | Lam et al. | Apr 1992 | A |
5108420 | Marks | Apr 1992 | A |
5201880 | Wright et al. | Apr 1993 | A |
5258008 | Wilk | Nov 1993 | A |
5300034 | Behnke et al. | Apr 1994 | A |
5325845 | Adair | Jul 1994 | A |
5346498 | Greelis et al. | Sep 1994 | A |
5383852 | Stevens-Wright | Jan 1995 | A |
5415656 | Tihon | May 1995 | A |
5449368 | Kuzmak | Sep 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5464404 | Abela et al. | Nov 1995 | A |
5474518 | Farrer Velazquez | Dec 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5593424 | Northrup, III | Jan 1997 | A |
5601572 | Middleman et al. | Feb 1997 | A |
5626609 | Zvenyatsky et al. | May 1997 | A |
5643317 | Pavcnik et al. | Jul 1997 | A |
5649908 | Itoh | Jul 1997 | A |
5669919 | Sanders et al. | Sep 1997 | A |
5676653 | Taylor et al. | Oct 1997 | A |
5683402 | Cosgrove et al. | Nov 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5693059 | Yoon | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5702398 | Tarabishy | Dec 1997 | A |
5709695 | Northrup, III | Jan 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5716397 | Myers | Feb 1998 | A |
5728116 | Rosenman | Mar 1998 | A |
5730150 | Peppel et al. | Mar 1998 | A |
5749371 | Zadini et al. | May 1998 | A |
5782844 | Yoon et al. | Jul 1998 | A |
5810882 | Bolduc et al. | Sep 1998 | A |
5824066 | Gross | Oct 1998 | A |
5830221 | Stein et al. | Nov 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5876373 | Giba et al. | Mar 1999 | A |
5879295 | Li | Mar 1999 | A |
5935098 | Blaisdell et al. | Aug 1999 | A |
5957953 | DiPoto et al. | Sep 1999 | A |
5961440 | Schweich, Jr. et al. | Oct 1999 | A |
5961539 | Northrup, III et al. | Oct 1999 | A |
5984959 | Robertson et al. | Nov 1999 | A |
6042554 | Rosenman et al. | Mar 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6048329 | Thompson | Apr 2000 | A |
6050936 | Schweich, Jr. et al. | Apr 2000 | A |
6059715 | Schweich, Jr. et al. | May 2000 | A |
6071279 | Whayne | Jun 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6074401 | Gardiner et al. | Jun 2000 | A |
6074417 | Peredo | Jun 2000 | A |
6086582 | Altman et al. | Jul 2000 | A |
6102945 | Campbell | Aug 2000 | A |
6106550 | Magovern et al. | Aug 2000 | A |
6110200 | Hinnenkamp | Aug 2000 | A |
6132390 | Cookston et al. | Oct 2000 | A |
6143024 | Campbell et al. | Nov 2000 | A |
6159240 | Sparer et al. | Dec 2000 | A |
6165119 | Schweich, Jr. et al. | Dec 2000 | A |
6174332 | Loch et al. | Jan 2001 | B1 |
6183411 | Mortier et al. | Feb 2001 | B1 |
6187040 | Wright | Feb 2001 | B1 |
6203525 | Whayne | Mar 2001 | B1 |
6210347 | Forsell | Apr 2001 | B1 |
6217528 | Koblish | Apr 2001 | B1 |
6217610 | Carpentier et al. | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6296656 | Bolduc et al. | Oct 2001 | B1 |
6315784 | Djurovic | Nov 2001 | B1 |
6319281 | Patel | Nov 2001 | B1 |
6328746 | Gambale | Dec 2001 | B1 |
6332880 | Yang | Dec 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6355030 | Aldrich et al. | Mar 2002 | B1 |
6361559 | Houser et al. | Mar 2002 | B1 |
6368348 | Gabbay | Apr 2002 | B1 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6406493 | Tu et al. | Jun 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6451054 | Stevens | Sep 2002 | B1 |
6458076 | Pruitt | Oct 2002 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6470892 | Forsell | Oct 2002 | B1 |
6503274 | Howanec, Jr. et al. | Jan 2003 | B1 |
6524338 | Gundry | Feb 2003 | B1 |
6530952 | Veseiy | Mar 2003 | B2 |
6533772 | Sherts et al. | Mar 2003 | B1 |
6537314 | Langberg et al. | Mar 2003 | B2 |
6542781 | Koblish | Apr 2003 | B1 |
6547801 | Dargent et al. | Apr 2003 | B1 |
6554845 | Fleenor et al. | Apr 2003 | B1 |
6564805 | Garrison et al. | May 2003 | B2 |
6565603 | Cox | May 2003 | B2 |
6569198 | Wilson et al. | May 2003 | B1 |
6579297 | Bicek et al. | Jun 2003 | B2 |
6589160 | Schweich, Jr. et al. | Jul 2003 | B2 |
6592593 | Parodi et al. | Jul 2003 | B1 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6602289 | Colvin et al. | Aug 2003 | B1 |
6613046 | Jenkins | Sep 2003 | B1 |
6613078 | Barone | Sep 2003 | B1 |
6613079 | Wolinsky et al. | Sep 2003 | B1 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6626917 | Craig | Sep 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629921 | Schweich, Jr. et al. | Oct 2003 | B1 |
6632184 | Truwit | Oct 2003 | B1 |
6645195 | Bhat | Nov 2003 | B1 |
6651671 | Donlon et al. | Nov 2003 | B1 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6682558 | Tu et al. | Jan 2004 | B2 |
6689125 | Keith et al. | Feb 2004 | B1 |
6689164 | Seguin | Feb 2004 | B1 |
6695866 | Kuehn et al. | Feb 2004 | B1 |
6702826 | Liddicoat et al. | Mar 2004 | B2 |
6702846 | Mikus et al. | Mar 2004 | B2 |
6706065 | Langberg et al. | Mar 2004 | B2 |
6709385 | Forsell | Mar 2004 | B2 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6711444 | Koblish | Mar 2004 | B2 |
6719786 | Ryan et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6726716 | Marquez | Apr 2004 | B2 |
6726717 | Alfieri et al. | Apr 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6749630 | McCarthy et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764310 | Ichihashi et al. | Jul 2004 | B1 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6764810 | Ma et al. | Jul 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6786924 | Ryan et al. | Sep 2004 | B2 |
6786925 | Schoon et al. | Sep 2004 | B1 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6797001 | Mathis et al. | Sep 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6802319 | Stevens et al. | Oct 2004 | B2 |
6805710 | Bolling et al. | Oct 2004 | B2 |
6805711 | Quijano et al. | Oct 2004 | B2 |
6855126 | Flinchbaugh | Feb 2005 | B2 |
6858039 | McCarthy | Feb 2005 | B2 |
6884250 | Monassevitch et al. | Apr 2005 | B2 |
6893459 | Macoviak | May 2005 | B1 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6908482 | McCarthy et al. | Jun 2005 | B2 |
6916306 | Jenkins | Jul 2005 | B1 |
6918917 | Nguyen et al. | Jul 2005 | B1 |
6926730 | Nguyen et al. | Aug 2005 | B1 |
6960217 | Bolduc | Nov 2005 | B2 |
6964684 | Ortiz et al. | Nov 2005 | B2 |
6964686 | Gordon | Nov 2005 | B2 |
6976995 | Mathis et al. | Dec 2005 | B2 |
6986775 | Morales et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6997951 | Solem et al. | Feb 2006 | B2 |
7004176 | Lau | Feb 2006 | B2 |
7007798 | Happonen et al. | Mar 2006 | B2 |
7011669 | Kimblad | Mar 2006 | B2 |
7011682 | Lashinski et al. | Mar 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7087064 | Hyde | Jun 2006 | B1 |
7077850 | Kortenbach | Jul 2006 | B2 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7112207 | Allen et al. | Sep 2006 | B2 |
7118595 | Ryan et al. | Oct 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7150737 | Purdy et al. | Dec 2006 | B2 |
7159593 | McCarthy et al. | Jan 2007 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7169187 | Datta et al. | Jan 2007 | B2 |
7172625 | Shu et al. | Feb 2007 | B2 |
7175660 | Cartledge et al. | Feb 2007 | B2 |
7186262 | Saadat | Mar 2007 | B2 |
7186264 | Liddicoat et al. | Mar 2007 | B2 |
7189199 | McCarthy et al. | Mar 2007 | B2 |
7192443 | Solem et al. | Mar 2007 | B2 |
7220277 | Arru et al. | May 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7226477 | Cox | Jun 2007 | B2 |
7226647 | Kasperchik et al. | Jun 2007 | B2 |
7229452 | Kayan | Jun 2007 | B2 |
7238191 | Bachmann | Jul 2007 | B2 |
7288097 | Seguin | Oct 2007 | B2 |
7294148 | McCarthy | Nov 2007 | B2 |
7311728 | Solem et al. | Dec 2007 | B2 |
7311729 | Mathis et al. | Dec 2007 | B2 |
7314485 | Mathis | Jan 2008 | B2 |
7316710 | Cheng et al. | Jan 2008 | B1 |
7329279 | Haug et al. | Feb 2008 | B2 |
7329280 | Bolling et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7361190 | Shaoulian et al. | Apr 2008 | B2 |
7364588 | Mathis et al. | Apr 2008 | B2 |
7377941 | Rhee et al. | May 2008 | B2 |
7390329 | Westra et al. | Jun 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7431692 | Zollinger et al. | Oct 2008 | B2 |
7442207 | Rafiee | Oct 2008 | B2 |
7452376 | Lim et al. | Nov 2008 | B2 |
7455690 | Cartledge et al. | Nov 2008 | B2 |
7485142 | Milo | Feb 2009 | B2 |
7485143 | Webler et al. | Feb 2009 | B2 |
7500989 | Solem et al. | Mar 2009 | B2 |
7507252 | Lashinski et al. | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7510577 | Moaddeb et al. | Mar 2009 | B2 |
7527647 | Spence | May 2009 | B2 |
7530995 | Quijano et al. | May 2009 | B2 |
7549983 | Roue et al. | Jun 2009 | B2 |
7559936 | Levine | Jul 2009 | B2 |
7562660 | Saadat | Jul 2009 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7563273 | Goldfarb et al. | Jul 2009 | B2 |
7569062 | Kuehn et al. | Aug 2009 | B1 |
7585321 | Cribier | Sep 2009 | B2 |
7588562 | Starksen et al. | Sep 2009 | B2 |
7591326 | Alferness et al. | Sep 2009 | B2 |
7604646 | Goldfarb et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7608103 | McCarthy | Oct 2009 | B2 |
7625403 | Krivoruchko | Dec 2009 | B2 |
7632303 | Stalker et al. | Dec 2009 | B1 |
7635329 | Goldfarb et al. | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7655015 | Goldfarb et al. | Feb 2010 | B2 |
7666204 | Thornton et al. | Feb 2010 | B2 |
7682319 | Martin et al. | Mar 2010 | B2 |
7682369 | Seguin | Mar 2010 | B2 |
7686822 | Shayani | Mar 2010 | B2 |
7699892 | Rafiee et al. | Apr 2010 | B2 |
7704269 | St. Goar et al. | Apr 2010 | B2 |
7704277 | Zakay et al. | Apr 2010 | B2 |
7713278 | Hess et al. | May 2010 | B2 |
7722666 | Lafontaine | May 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753924 | Starksen et al. | Jul 2010 | B2 |
7758632 | Hojeibane et al. | Jul 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7871368 | Zollinger et al. | Jan 2011 | B2 |
7871433 | Lattouf | Jan 2011 | B2 |
7883475 | Dupont et al. | Feb 2011 | B2 |
7883538 | To et al. | Feb 2011 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7927370 | Webier et al. | Apr 2011 | B2 |
7927371 | Navia et al. | Apr 2011 | B2 |
7942927 | Kaye et al. | May 2011 | B2 |
7947056 | Griego et al. | May 2011 | B2 |
7955315 | Feinberg et al. | Jun 2011 | B2 |
7955377 | Melsheirner | Jun 2011 | B2 |
7992567 | Hirotsuka et al. | Aug 2011 | B2 |
7993368 | Gambale et al. | Aug 2011 | B2 |
7993397 | Lashinski et al. | Aug 2011 | B2 |
8012201 | Lashinski et al. | Sep 2011 | B2 |
8034103 | Burriesci et al. | Oct 2011 | B2 |
8052592 | Goldfarb et al. | Nov 2011 | B2 |
8057493 | Goldfarb et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8070804 | Hyde et al. | Dec 2011 | B2 |
8070805 | Vidlund et al. | Dec 2011 | B2 |
8075616 | Solem et al. | Dec 2011 | B2 |
8100964 | Spence | Jan 2012 | B2 |
8123801 | Milo | Feb 2012 | B2 |
8142493 | Spence et al. | Mar 2012 | B2 |
8142495 | Hasenkam et al. | Mar 2012 | B2 |
8142496 | Berreklouw | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8152844 | Rao et al. | Apr 2012 | B2 |
8163013 | Machold et al. | Apr 2012 | B2 |
8187299 | Goldfarb et al. | May 2012 | B2 |
8187324 | Webler et al. | May 2012 | B2 |
8202315 | Hlavka et al. | Jun 2012 | B2 |
8206439 | Gomez Duran | Jun 2012 | B2 |
8216302 | Wilson et al. | Jul 2012 | B2 |
8231671 | Kim | Jul 2012 | B2 |
8262725 | Subramanian | Sep 2012 | B2 |
8265758 | Policker et al. | Sep 2012 | B2 |
8277502 | Miller et al. | Oct 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8287591 | Keidar et al. | Oct 2012 | B2 |
8292884 | Levine et al. | Oct 2012 | B2 |
8303608 | Goldfarb et al. | Nov 2012 | B2 |
8323334 | Deem et al. | Dec 2012 | B2 |
8328868 | Paul et al. | Dec 2012 | B2 |
8333777 | Schaller et al. | Dec 2012 | B2 |
8343173 | Starksen et al. | Jan 2013 | B2 |
8343174 | Goldfarb et al. | Jan 2013 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8349002 | Milo | Jan 2013 | B2 |
8353956 | Miller et al. | Jan 2013 | B2 |
8357195 | Kuehn | Jan 2013 | B2 |
8382829 | Call et al. | Feb 2013 | B1 |
8388680 | Starksen et al. | Mar 2013 | B2 |
8393517 | Milo | Mar 2013 | B2 |
8419825 | Burgler et al. | Apr 2013 | B2 |
8430926 | Kirson | Apr 2013 | B2 |
8449573 | Chu | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8460370 | Zakay | Jun 2013 | B2 |
8460371 | Hlavka et al. | Jun 2013 | B2 |
8475491 | Milo | Jul 2013 | B2 |
8475525 | Maisano et al. | Jul 2013 | B2 |
8480732 | Subramanian | Jul 2013 | B2 |
8518107 | Tsukashima et al. | Aug 2013 | B2 |
8523940 | Richardson et al. | Sep 2013 | B2 |
8551161 | Dolan | Oct 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8591576 | Hasenkam et al. | Nov 2013 | B2 |
8602970 | Muyari | Dec 2013 | B2 |
8608797 | Gross et al. | Dec 2013 | B2 |
8628569 | Benichou et al. | Jan 2014 | B2 |
8628571 | Hacohen et al. | Jan 2014 | B1 |
8641727 | Starksen et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8728097 | Sugimoto et al. | May 2014 | B1 |
8728155 | Montorfano et al. | May 2014 | B2 |
8734467 | Miller et al. | May 2014 | B2 |
8734699 | Heideman et al. | May 2014 | B2 |
8740920 | Goldfarb et al. | Jun 2014 | B2 |
8747463 | Fogarty et al. | Jun 2014 | B2 |
8778021 | Cartledge | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8790367 | Nguyen et al. | Jul 2014 | B2 |
8790394 | Miller et al. | Jul 2014 | B2 |
8795298 | Hernlund et al. | Aug 2014 | B2 |
8795355 | Alkhatib | Aug 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8808368 | Maisano et al. | Aug 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8845723 | Spence et al. | Sep 2014 | B2 |
8852261 | White | Oct 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8858623 | Miller et al. | Oct 2014 | B2 |
8864822 | Spence et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870949 | Rowe | Oct 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8889861 | Skead et al. | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8911461 | Traynor et al. | Dec 2014 | B2 |
8911494 | Hammer et al. | Dec 2014 | B2 |
8926696 | Cabiri et al. | Jan 2015 | B2 |
8926697 | Gross et al. | Jan 2015 | B2 |
8932343 | Alkhatib et al. | Jan 2015 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8940044 | Hammer et al. | Jan 2015 | B2 |
8945211 | Sugimoto | Feb 2015 | B2 |
8951285 | Sugimoto et al. | Feb 2015 | B2 |
8951286 | Sugimoto et al. | Feb 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8961602 | Kovach et al. | Feb 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8992420 | Maahs | Mar 2015 | B2 |
8992604 | Gross et al. | Mar 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011520 | Miller et al. | Apr 2015 | B2 |
9011530 | Reich et al. | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9107749 | Bobo et al. | Aug 2015 | B2 |
9119719 | Zipory et al. | Sep 2015 | B2 |
9125632 | Loulmet et al. | Sep 2015 | B2 |
9125742 | Yoganathan et al. | Sep 2015 | B2 |
9138316 | Bielefeld | Sep 2015 | B2 |
9173646 | Fabro | Nov 2015 | B2 |
9180005 | Lashinski et al. | Nov 2015 | B1 |
9180007 | Reich et al. | Nov 2015 | B2 |
9192472 | Gross et al. | Nov 2015 | B2 |
9198756 | Aklog et al. | Dec 2015 | B2 |
9226825 | Starksen et al. | Jan 2016 | B2 |
9265608 | Miller et al. | Feb 2016 | B2 |
9326857 | Cartledge et al. | May 2016 | B2 |
9414921 | Miller et al. | Aug 2016 | B2 |
9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
9474606 | Zipory et al. | Oct 2016 | B2 |
9526613 | Gross et al. | Dec 2016 | B2 |
9561104 | Miller et al. | Feb 2017 | B2 |
9693865 | Gilmore et al. | Jul 2017 | B2 |
9724195 | Goodwin | Aug 2017 | B2 |
9730793 | Reich et al. | Aug 2017 | B2 |
9788941 | Hacohen | Oct 2017 | B2 |
9801720 | Gilmore et al. | Oct 2017 | B2 |
9907547 | Gilmore et al. | Mar 2018 | B2 |
10368852 | Gerhardt et al. | Aug 2019 | B2 |
20010021874 | Carpentier et al. | Sep 2001 | A1 |
20020022862 | Grafton et al. | Feb 2002 | A1 |
20020082525 | Oslund et al. | Jun 2002 | A1 |
20020087048 | Brock et al. | Jul 2002 | A1 |
20020103532 | Langberg et al. | Aug 2002 | A1 |
20020151916 | Muramatsu et al. | Oct 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020169358 | Mortier et al. | Nov 2002 | A1 |
20020177904 | Huxel et al. | Nov 2002 | A1 |
20020188301 | Dallara et al. | Dec 2002 | A1 |
20020188350 | Arru et al. | Dec 2002 | A1 |
20020198586 | Inoue | Dec 2002 | A1 |
20030050693 | Quijano et al. | Mar 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078653 | Vesely et al. | Apr 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030114901 | Loeb et al. | Jun 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030144657 | Bowe et al. | Jul 2003 | A1 |
20030171760 | Gambale | Sep 2003 | A1 |
20030199974 | Lee et al. | Oct 2003 | A1 |
20030204195 | Keane et al. | Oct 2003 | A1 |
20030229350 | Kay | Dec 2003 | A1 |
20030229395 | Cox | Dec 2003 | A1 |
20040010287 | Bonutti | Jan 2004 | A1 |
20040019359 | Worley et al. | Jan 2004 | A1 |
20040019377 | Taylor et al. | Jan 2004 | A1 |
20040024451 | Johnson et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040059413 | Argento | Mar 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040133274 | Webler et al. | Jul 2004 | A1 |
20040133374 | Kattan | Jul 2004 | A1 |
20040138744 | Lashinski et al. | Jul 2004 | A1 |
20040138745 | Macoviak et al. | Jul 2004 | A1 |
20040148019 | Vidlund et al. | Jul 2004 | A1 |
20040148020 | Vidlund et al. | Jul 2004 | A1 |
20040148021 | Cartledge et al. | Jul 2004 | A1 |
20040162568 | Saadat | Aug 2004 | A1 |
20040176788 | Opolski | Sep 2004 | A1 |
20040181287 | Gellman | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20040267358 | Reitan | Dec 2004 | A1 |
20050004668 | Aklog et al. | Jan 2005 | A1 |
20050010287 | Macoviak et al. | Jan 2005 | A1 |
20050010787 | Tarbouriech | Jan 2005 | A1 |
20050016560 | Voughlohn | Jan 2005 | A1 |
20050049692 | Numamoto et al. | Mar 2005 | A1 |
20050055038 | Kelleher et al. | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050065601 | Lee et al. | Mar 2005 | A1 |
20050070999 | Spence | Mar 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050090827 | Gedebou | Apr 2005 | A1 |
20050090834 | Chiang et al. | Apr 2005 | A1 |
20050096740 | Langberg et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050119734 | Spence et al. | Jun 2005 | A1 |
20050125002 | Baran et al. | Jun 2005 | A1 |
20050125011 | Spence et al. | Jun 2005 | A1 |
20050131533 | Alfieri et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137700 | Spence | Jun 2005 | A1 |
20050159728 | Armour et al. | Jul 2005 | A1 |
20050171601 | Cosgrove et al. | Aug 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050177228 | Solem et al. | Aug 2005 | A1 |
20050187568 | Klenk et al. | Aug 2005 | A1 |
20050192596 | Jugenheimer et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203606 | VanCamp | Sep 2005 | A1 |
20050216039 | Lederman | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050222665 | Aranyi | Oct 2005 | A1 |
20050234296 | Saadat | Oct 2005 | A1 |
20050256532 | Nayak et al. | Nov 2005 | A1 |
20050267478 | Corradi et al. | Dec 2005 | A1 |
20050272977 | Saadat | Dec 2005 | A1 |
20050273138 | To et al. | Dec 2005 | A1 |
20050288778 | Shaoulian et al. | Dec 2005 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060004443 | Liddicoat et al. | Jan 2006 | A1 |
20060020326 | Bolduc et al. | Jan 2006 | A9 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020333 | Lashinski et al. | Jan 2006 | A1 |
20060020336 | Liddicoat | Jan 2006 | A1 |
20060025787 | Morales et al. | Feb 2006 | A1 |
20060025858 | Alameddine | Feb 2006 | A1 |
20060030885 | Hyde | Feb 2006 | A1 |
20060041319 | Taylor et al. | Feb 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060074486 | Liddicoat et al. | Apr 2006 | A1 |
20060085012 | Dolan | Apr 2006 | A1 |
20060095009 | Lampropoulos et al. | May 2006 | A1 |
20060106423 | Weisel et al. | May 2006 | A1 |
20060116757 | Lashinski et al. | Jun 2006 | A1 |
20060122633 | To et al. | Jun 2006 | A1 |
20060129166 | Lavelle | Jun 2006 | A1 |
20060149280 | Harvie et al. | Jul 2006 | A1 |
20060149368 | Spence | Jul 2006 | A1 |
20060161265 | Levine et al. | Jul 2006 | A1 |
20060184240 | Jimenez et al. | Aug 2006 | A1 |
20060184242 | Lichtenstein | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060206203 | Yang et al. | Sep 2006 | A1 |
20060241622 | Zergiebel | Oct 2006 | A1 |
20060241656 | Starksen et al. | Oct 2006 | A1 |
20060241748 | Lee et al. | Oct 2006 | A1 |
20060247763 | Slater | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287661 | Bolduc et al. | Dec 2006 | A1 |
20060287716 | Banbury et al. | Dec 2006 | A1 |
20070001627 | Lin et al. | Jan 2007 | A1 |
20070016287 | Cartledge et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070021781 | Jervis et al. | Jan 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070027536 | Mihaljevic et al. | Feb 2007 | A1 |
20070038221 | Fine et al. | Feb 2007 | A1 |
20070038293 | St Goar et al. | Feb 2007 | A1 |
20070038296 | Navia et al. | Feb 2007 | A1 |
20070039425 | Wang | Feb 2007 | A1 |
20070049942 | Hindrichs et al. | Mar 2007 | A1 |
20070049970 | Belef et al. | Mar 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055206 | To et al. | Mar 2007 | A1 |
20070061010 | Hauser et al. | Mar 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070078297 | Rafiee et al. | Apr 2007 | A1 |
20070080188 | Spence et al. | Apr 2007 | A1 |
20070083168 | Whiting et al. | Apr 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070106328 | Wardle et al. | May 2007 | A1 |
20070112359 | Kimura et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070118154 | Crabtree | May 2007 | A1 |
20070118213 | Loulmet | May 2007 | A1 |
20070118215 | Moaddeb | May 2007 | A1 |
20070142907 | Moaddeb et al. | Jun 2007 | A1 |
20070162111 | Fukamachi et al. | Jul 2007 | A1 |
20070198082 | Kapadia et al. | Aug 2007 | A1 |
20070219558 | Deutsch | Sep 2007 | A1 |
20070239208 | Crawford | Oct 2007 | A1 |
20070255397 | Ryan et al. | Nov 2007 | A1 |
20070255400 | Parravicini et al. | Nov 2007 | A1 |
20070270755 | Von Oepen et al. | Nov 2007 | A1 |
20070276437 | Call et al. | Nov 2007 | A1 |
20070282375 | Hindrichs et al. | Dec 2007 | A1 |
20070282429 | Hauser et al. | Dec 2007 | A1 |
20070295172 | Swartz | Dec 2007 | A1 |
20070299387 | Williams | Dec 2007 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080027483 | Cartledge et al. | Jan 2008 | A1 |
20080027555 | Hawkins | Jan 2008 | A1 |
20080035160 | Woodson et al. | Feb 2008 | A1 |
20080039935 | Buch et al. | Feb 2008 | A1 |
20080051703 | Thornton et al. | Feb 2008 | A1 |
20080058595 | Snoke et al. | Mar 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080065204 | Macoviak et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080086138 | Stone et al. | Apr 2008 | A1 |
20080086203 | Roberts | Apr 2008 | A1 |
20080091169 | Heideman et al. | Apr 2008 | A1 |
20080091257 | Andreas et al. | Apr 2008 | A1 |
20080097523 | Bolduc et al. | Apr 2008 | A1 |
20080103572 | Gerber | May 2008 | A1 |
20080140116 | Bonutti | Jun 2008 | A1 |
20080167713 | Bolling | Jul 2008 | A1 |
20080167714 | St. Goar et al. | Jul 2008 | A1 |
20080195126 | Solem | Aug 2008 | A1 |
20080195200 | Vidlund et al. | Aug 2008 | A1 |
20080208265 | Frazier et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080228165 | Spence et al. | Sep 2008 | A1 |
20080228267 | Spence et al. | Sep 2008 | A1 |
20080262480 | Stahler et al. | Oct 2008 | A1 |
20080262609 | Gross et al. | Oct 2008 | A1 |
20080275300 | Rothe et al. | Nov 2008 | A1 |
20080275469 | Fanton et al. | Nov 2008 | A1 |
20080275551 | Alfieri | Nov 2008 | A1 |
20080281353 | Aranyi et al. | Nov 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080288044 | Osborne | Nov 2008 | A1 |
20080288062 | Andrieu et al. | Nov 2008 | A1 |
20080300537 | Bowman | Dec 2008 | A1 |
20080300629 | Surti | Dec 2008 | A1 |
20090028670 | Garcia et al. | Jan 2009 | A1 |
20090043381 | Macoviak et al. | Feb 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090062866 | Jackson | Mar 2009 | A1 |
20090076586 | Hauser et al. | Mar 2009 | A1 |
20090076600 | Quinn | Mar 2009 | A1 |
20090088837 | Gillinov et al. | Apr 2009 | A1 |
20090093877 | Keidar et al. | Apr 2009 | A1 |
20090099650 | Bolduc et al. | Apr 2009 | A1 |
20090105816 | Olsen et al. | Apr 2009 | A1 |
20090125102 | Cartledge et al. | May 2009 | A1 |
20090163934 | Raschdorf et al. | Jun 2009 | A1 |
20090171439 | Nissl | Jul 2009 | A1 |
20090177266 | Powell et al. | Jul 2009 | A1 |
20090177274 | Scorsin et al. | Jul 2009 | A1 |
20090182268 | Thielen | Jul 2009 | A1 |
20090204083 | O'Donnell | Aug 2009 | A1 |
20090240206 | Lunn et al. | Sep 2009 | A1 |
20090248148 | Shaolian et al. | Oct 2009 | A1 |
20090254103 | Deutsch | Oct 2009 | A1 |
20090264994 | Saadat | Oct 2009 | A1 |
20090287231 | Brooks et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20090299409 | Coe et al. | Dec 2009 | A1 |
20090306757 | Meyer | Dec 2009 | A1 |
20090326648 | Machold et al. | Dec 2009 | A1 |
20100001038 | Levin et al. | Jan 2010 | A1 |
20100010538 | Juravic et al. | Jan 2010 | A1 |
20100016655 | Annest et al. | Jan 2010 | A1 |
20100023118 | Medlock et al. | Jan 2010 | A1 |
20100030014 | Ferrazzi | Feb 2010 | A1 |
20100030328 | Seguin et al. | Feb 2010 | A1 |
20100042147 | Janovsky et al. | Feb 2010 | A1 |
20100056985 | Weber | Mar 2010 | A1 |
20100063542 | van der Burg et al. | Mar 2010 | A1 |
20100063550 | Felix et al. | Mar 2010 | A1 |
20100076499 | McNamara et al. | Mar 2010 | A1 |
20100094248 | Nguyen et al. | Apr 2010 | A1 |
20100114180 | Rock et al. | May 2010 | A1 |
20100121349 | Meier et al. | May 2010 | A1 |
20100121435 | Subramanian et al. | May 2010 | A1 |
20100121437 | Subramanian et al. | May 2010 | A1 |
20100130992 | Machold et al. | May 2010 | A1 |
20100152845 | Bloom et al. | Jun 2010 | A1 |
20100161043 | Maisano et al. | Jun 2010 | A1 |
20100168845 | Wright | Jul 2010 | A1 |
20100174358 | Rabkin et al. | Jul 2010 | A1 |
20100179574 | Longoria et al. | Jul 2010 | A1 |
20100217184 | Koblish et al. | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100234935 | Bashiri et al. | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100249915 | Zhang | Sep 2010 | A1 |
20100249920 | Bolling et al. | Sep 2010 | A1 |
20100262232 | Annest | Oct 2010 | A1 |
20100262233 | He | Oct 2010 | A1 |
20100280316 | Dietz | Nov 2010 | A1 |
20100286628 | Gross | Nov 2010 | A1 |
20100292614 | Delaney | Nov 2010 | A1 |
20100305475 | Hinchliffe et al. | Dec 2010 | A1 |
20100324598 | Anderson | Dec 2010 | A1 |
20110004210 | Johnson et al. | Jan 2011 | A1 |
20110004298 | Lee et al. | Jan 2011 | A1 |
20110009956 | Cartledge et al. | Jan 2011 | A1 |
20110011917 | Loulmet | Jan 2011 | A1 |
20110026208 | Utsuro et al. | Feb 2011 | A1 |
20110029066 | Gilad et al. | Feb 2011 | A1 |
20110035000 | Nieminen et al. | Feb 2011 | A1 |
20110066231 | Cartledge et al. | Mar 2011 | A1 |
20110067770 | Pederson et al. | Mar 2011 | A1 |
20110071626 | Wright et al. | Mar 2011 | A1 |
20110082538 | Dahlgren et al. | Apr 2011 | A1 |
20110087146 | Ryan et al. | Apr 2011 | A1 |
20110093002 | Rucker et al. | Apr 2011 | A1 |
20110118832 | Punjabi | May 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110144703 | Krause et al. | Jun 2011 | A1 |
20110202130 | Cartledge et al. | Aug 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110230941 | Markus | Sep 2011 | A1 |
20110230961 | Langer et al. | Sep 2011 | A1 |
20110238088 | Bolduc et al. | Sep 2011 | A1 |
20110257433 | Walker | Oct 2011 | A1 |
20110257633 | Cartledge et al. | Oct 2011 | A1 |
20110264208 | Duffy et al. | Oct 2011 | A1 |
20110276062 | Bolduc | Nov 2011 | A1 |
20110288435 | Christy et al. | Nov 2011 | A1 |
20110301498 | Maenhout et al. | Dec 2011 | A1 |
20120078355 | Zipory et al. | Mar 2012 | A1 |
20120078359 | Li et al. | Mar 2012 | A1 |
20120089022 | House et al. | Apr 2012 | A1 |
20120095552 | Spence et al. | Apr 2012 | A1 |
20120109155 | Robinson et al. | May 2012 | A1 |
20120150290 | Gabbay | Jun 2012 | A1 |
20120158021 | Morrill | Jun 2012 | A1 |
20120179086 | Shank et al. | Jul 2012 | A1 |
20120191182 | Hauser et al. | Jul 2012 | A1 |
20120226349 | Tuval et al. | Sep 2012 | A1 |
20120232346 | Suda | Sep 2012 | A1 |
20120239142 | Liu et al. | Sep 2012 | A1 |
20120245604 | Tegzes | Sep 2012 | A1 |
20120271198 | Whittaker et al. | Oct 2012 | A1 |
20120296349 | Smith et al. | Nov 2012 | A1 |
20120296417 | Hill et al. | Nov 2012 | A1 |
20120310330 | Buchbinder et al. | Dec 2012 | A1 |
20120323313 | Seguin | Dec 2012 | A1 |
20130030522 | Rowe et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130085529 | Housman | Apr 2013 | A1 |
20130090631 | Anderson | Apr 2013 | A1 |
20130090724 | Subramanian et al. | Apr 2013 | A1 |
20130096673 | Hill et al. | Apr 2013 | A1 |
20130116776 | Gross et al. | May 2013 | A1 |
20130123910 | Cartledge et al. | May 2013 | A1 |
20130131791 | Hlavka et al. | May 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130184528 | Onuki | Jul 2013 | A1 |
20130190863 | Call et al. | Jul 2013 | A1 |
20130204361 | Adams et al. | Aug 2013 | A1 |
20130226289 | Shaolian et al. | Aug 2013 | A1 |
20130226290 | Yellin et al. | Aug 2013 | A1 |
20130268069 | Zakai et al. | Oct 2013 | A1 |
20130289718 | Tsukashima et al. | Oct 2013 | A1 |
20130297013 | Klima et al. | Nov 2013 | A1 |
20130304093 | Serina et al. | Nov 2013 | A1 |
20140081394 | Keranen et al. | Mar 2014 | A1 |
20140088368 | Park | Mar 2014 | A1 |
20140094826 | Sutherland et al. | Apr 2014 | A1 |
20140094903 | Miller et al. | Apr 2014 | A1 |
20140094906 | Spence et al. | Apr 2014 | A1 |
20140114390 | Tobis et al. | Apr 2014 | A1 |
20140135799 | Henderson | May 2014 | A1 |
20140142619 | Serina et al. | May 2014 | A1 |
20140142695 | Gross et al. | May 2014 | A1 |
20140148849 | Serina et al. | May 2014 | A1 |
20140155783 | Starksen et al. | Jun 2014 | A1 |
20140163670 | Alon et al. | Jun 2014 | A1 |
20140163690 | White | Jun 2014 | A1 |
20140188108 | Goodine et al. | Jul 2014 | A1 |
20140188140 | Meter et al. | Jul 2014 | A1 |
20140188215 | Hlavka et al. | Jul 2014 | A1 |
20140194976 | Starksen et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140243859 | Robinson | Aug 2014 | A1 |
20140243894 | Groothuis et al. | Aug 2014 | A1 |
20140243963 | Sheps et al. | Aug 2014 | A1 |
20140275757 | Goodwin et al. | Sep 2014 | A1 |
20140276648 | Hammer et al. | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140303649 | Nguyen et al. | Oct 2014 | A1 |
20140303720 | Sugimoto et al. | Oct 2014 | A1 |
20140309661 | Sheps et al. | Oct 2014 | A1 |
20140309730 | Alon et al. | Oct 2014 | A1 |
20140343668 | Zipory et al. | Nov 2014 | A1 |
20140350660 | Cocks et al. | Nov 2014 | A1 |
20140379006 | Sutherland et al. | Dec 2014 | A1 |
20150018940 | Quill et al. | Jan 2015 | A1 |
20150051697 | Spence et al. | Feb 2015 | A1 |
20150081014 | Gross et al. | Mar 2015 | A1 |
20150112432 | Reich et al. | Apr 2015 | A1 |
20150127097 | Neumann et al. | May 2015 | A1 |
20150182336 | Zipory et al. | Jul 2015 | A1 |
20150272586 | Herman et al. | Oct 2015 | A1 |
20150272734 | Sheps et al. | Oct 2015 | A1 |
20150282931 | Brunnett et al. | Oct 2015 | A1 |
20150351910 | Gilmore et al. | Dec 2015 | A1 |
20160008132 | Cabiri et al. | Jan 2016 | A1 |
20160058557 | Reich et al. | Mar 2016 | A1 |
20160113767 | Miller et al. | Apr 2016 | A1 |
20160120645 | Alon | May 2016 | A1 |
20160158008 | Miller et al. | Jun 2016 | A1 |
20160242762 | Gilmore et al. | Aug 2016 | A1 |
20160262755 | Zipory et al. | Sep 2016 | A1 |
20160302917 | Schewel | Oct 2016 | A1 |
20160317302 | Madjarov et al. | Nov 2016 | A1 |
20160361058 | Bolduc et al. | Dec 2016 | A1 |
20160361168 | Gross et al. | Dec 2016 | A1 |
20160361169 | Gross et al. | Dec 2016 | A1 |
20170000609 | Gross et al. | Jan 2017 | A1 |
20170224489 | Starksen et al. | Aug 2017 | A1 |
20170245993 | Gross et al. | Aug 2017 | A1 |
20180049875 | Iflah et al. | Feb 2018 | A1 |
20180318080 | Quill et al. | Nov 2018 | A1 |
20190038411 | Alon | Feb 2019 | A1 |
Number | Date | Country |
---|---|---|
1034753 | Sep 2000 | EP |
3531975 | Sep 2019 | EP |
9205093 | Apr 1992 | WO |
9846149 | Oct 1998 | WO |
02085250 | Feb 2003 | WO |
03047467 | Jun 2003 | WO |
WO2004098701 | Nov 2004 | WO |
2010000454 | Jan 2010 | WO |
WO 2012111761 | Aug 2012 | WO |
2012176195 | Mar 2013 | WO |
2014064964 | May 2014 | WO |
Entry |
---|
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009). |
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis,” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319. |
Ahmadi, Ali et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522. |
Alfieri et al,“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493. |
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999). |
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001). |
Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000). |
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000). |
Amplatzer Cardiac Plug brochure (English pages); AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011). |
AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008. |
AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008. |
Assad, Renato S. “Adjustable Pulmonary Artery Banding,” (2014). |
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008. |
Daebritz, S. et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52. |
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8(3) (2005). |
Dictionary,com definition of “lock”, Jul. 29, 2013. |
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003). |
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154. |
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007. |
Langer et al. RING+STRING, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008. |
Maisano, “The double-orifice technique as a standardized approach to treat mitral,” European Journal of Cardio-thoracic Surgery 17 (2000) 201-205. |
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006). |
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995). |
Park, Sang C. et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1965): 477-484. |
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994). |
Swenson, O. An experimental implantable urinary sphincter. Invest Urol. Sep. 1976;14(2):100-3. |
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391. |
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545. |
Tajik, Abdul, “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978. |
Number | Date | Country | |
---|---|---|---|
20180125659 A1 | May 2018 | US |
Number | Date | Country | |
---|---|---|---|
61786373 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14210967 | Mar 2014 | US |
Child | 15642963 | US |